Merck
Trade Merck 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About MRK
Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other.
MRK Key Statistics
Stock Snapshot
The current Merck(MRK) stock price is $119.59, with a market capitalization of 296.24B. The stock trades at a price-to-earnings (P/E) ratio of 16.46 and offers a dividend yield of 2.7%.
On 2026-03-04, Merck(MRK) stock moved within a range of $118.61 to $122.96. With shares now at $119.59, the stock is trading +0.8% above its intraday low and -2.7% below the session's peak.
Trading volume for Merck(MRK) stock has reached 9.33M, versus its average volume of 10.42M.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
Over the past 52 weeks, Merck(MRK) stock has traded between a high of $125.14 and a low of $73.31.
MRK News
Tempus AI Inc. (NASDAQ:TEM) on Tuesday inked a strategic collaboration agreement with Merck & Co. Inc. (NYSE:MRK) aimed at accelerating AI-driven precision medi...
Most Retirees Overlook These Dow Dividend Stocks — They Pay More Than You’d Expect Quick Read Chevron (CVX) up 83% over 25 years, Home Depot (HD) up 42% in 5 y...
Merck (NYSE:MRK) reported positive Phase 3 results for KEYTRUDA combinations in renal cell carcinoma, ovarian cancer, and bladder cancer. The company also secu...
Analyst ratings
61%
of 31 ratingsMore MRK News
Tempus AI (TEM) and Merck (MRK) announced an expanded, multi-year collaboration aimed at accelerating the discovery and development of precision medicine biomar...
Merck (MRK) closed the most recent trading day at $117.23, moving -1.19% from the previous trading session. This change lagged the S&P 500's 1.7% gain on the da...
RBC Capital lowered the firm’s price target on Exelixis (EXEL) to $43 from $46 and keeps a Sector Perform rating on the shares. The firm notes that competitive...
Merck (MRK), known as MSD outside of the United States and Canada, and Eisai (ESAIY) announced the first presentation of results from the Phase 3 LITESPARK-011...
In late February 2026, Synthekine announced a collaboration and supply agreement with Merck to test STK-012 alongside Keytruda and chemotherapy in the ongoing g...
Technology Merck Stock, Up 13% In 2026, Ticks Another Box. Is It Now A Buy? Licensing Merck (MRK) stock, which has climbed 13% in 2026, ticked another box Frida...
Merck (MRK) announced results from the final analysis of the pivotal Phase 3 KEYNOTE-B96 trial, also known as ENGOT-ov65, showing that KEYTRUDA, Merck’s anti-PD...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.